Smaill F, Hofmeyr G J
Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Room 2N29, 1200 Main Street West, Hamilton, Ontario, Canada, L8N 3Z5.
Cochrane Database Syst Rev. 2002(3):CD000933. doi: 10.1002/14651858.CD000933.
The single most important risk factor for postpartum maternal infection is cesarean delivery.
The objective of this review was to assess the effects of prophylactic antibiotic treatment on infectious complications in women undergoing cesarean delivery.
We searched the Cochrane Pregnancy and Childbirth Group trials register (January 2002) and the Cochrane Controlled Trials Register (The Cochrane Library, Issue 4, 2001).
Randomized trials comparing antibiotic prophylaxis or no treatment for both elective and non-elective cesarean section.
Two reviewers assessed trial quality and extracted data.
Eighty-one trials were included. Use of prophylactic antibiotics in women undergoing cesarean section substantially reduced the incidence of episodes of fever, endometritis, wound infection, urinary tract infection and serious infection after cesarean section. The reduction in the risk of endometritis with antibiotics was similar across different patient groups: the relative risk (RR) for endometritis for elective cesarean section (number of women = 2037) was 0.38 (95% confidence interval (CI) 0.22 to 0.64); the RR for non-elective cesarean section (n = 2132) was 0.39 (95% CI 0.34 to 0.46); and the RR for all patients (n = 11,937) was 0.39 (95% CI 0.31 to 0.43). Wound infections were also reduced: for elective cesarean section (n = 2015) RR 0.73 (95% CI 0.53 to 0.99); for non-elective cesarean section (n = 2780) RR 0.36 95% CI 0.26 to 0.51]; and for all patients (n = 11,142) RR 0.41 (95% CI 0.29 to 0.43).
REVIEWER'S CONCLUSIONS: The reduction of endometritis by two thirds to three quarters and a decrease in wound infections justifies a policy of recommending prophylactic antibiotics to women undergoing elective or non-elective cesarean section.
剖宫产是产后产妇感染的唯一最重要风险因素。
本综述的目的是评估预防性抗生素治疗对剖宫产妇女感染并发症的影响。
我们检索了Cochrane妊娠与分娩组试验注册库(2002年1月)和Cochrane对照试验注册库(《Cochrane图书馆》,2001年第4期)。
比较择期和非择期剖宫产预防性使用抗生素或不治疗的随机试验。
两名评价员评估试验质量并提取数据。
纳入81项试验。剖宫产妇女预防性使用抗生素可大幅降低剖宫产术后发热、子宫内膜炎、伤口感染、尿路感染和严重感染的发生率。不同患者组使用抗生素降低子宫内膜炎风险的情况相似:择期剖宫产(女性人数=2037)子宫内膜炎的相对风险(RR)为0.38(95%置信区间(CI)0.22至0.64);非择期剖宫产(n=2132)RR为0.39(95%CI 0.34至0.46);所有患者(n=11937)RR为0.39(95%CI 0.31至0.43)。伤口感染也有所减少:择期剖宫产(n=2015)RR为0.73(95%CI 0.53至0.99);非择期剖宫产(n=2780)RR为0.36(95%CI 0.26至0.51);所有患者(n=11142)RR为0.41(95%CI 0.29至0.43)。
将子宫内膜炎减少三分之二至四分之三以及伤口感染减少证明了对择期或非择期剖宫产妇女推荐预防性使用抗生素这一政策的合理性。